
Pharma sector expected to grow between 6 and 8 % YoY in FY23
The agency said that higher Capex in lieu of the ‘Production-linked Incentives’ (PLI) scheme will restrict the quantum of free cash flow generation during the year….reports Asian Lite News India’s pharmaceuticals market